Home

Friday, August 18, 2017 - 12:05
12 problem-solving haircare ingredients. Beauty store and salon owners, take note.While common sense may suggest that there’s no such thing as having too many choices, human nature dictates the opposite. Take the famous jam study, wherein sociologists set up two displays at a gourmet store. The first contained six preserve options, the other boasted an array of 24. All customers were offered a dollar-off coupon if they bought a jar. In the end, 30 percent of shoppers exposed to the smaller selection took home jelly, while only three percent of the latter group made a purchase.
http://beautystorebusiness.com/natural-selection
Thursday, August 17, 2017 - 14:14
A mouse study from the O’Donnell Brain Institute and University of California, Irvine, showed that eating at abnormal times disrupts the circadian rhythm of the skin and alters the potency of an enzyme that protects it against ultraviolet radiation.
http://medestheticsmag.com/eating-habits-affect-skin%E2%80%99s-ability-protect-itself-against-uv-rays
Thursday, August 17, 2017 - 14:14
A mouse study from the O’Donnell Brain Institute and University of California, Irvine, showed that eating at abnormal times disrupts the circadian rhythm of the skin and alters the potency of an enzyme that protects it against ultraviolet radiation.
http://medestheticsmag.com/eating-habits-affect-skin%E2%80%99s-ability-protect-itself-against-uv-rays

Advertisement - Box 1

Advertisement - Box 2

Thursday, August 17, 2017 - 14:12
A review study published in the September 2017 issue of the Journal of the American Academy of Dermatology supports the role of Demodex mites in rosacea. Ying Shuo-Chang, MD, and Yu-Chen Huang, MD, of Taipei Medical University Hospital, Taiwan, performed a literature search in PubMed, MEDLINE, and EmBase databases from inception through October 31, 2016. They searched the terms “Demodex” and “Demodex Mites” combined with “Rosacea.” All studies included in their review and meta-analysis were human clinical trials published in English.
http://medestheticsmag.com/new-evidence-demodex-mite-infestations-rosacea
Thursday, August 17, 2017 - 14:12
A review study published in the September 2017 issue of the Journal of the American Academy of Dermatology supports the role of Demodex mites in rosacea. Ying Shuo-Chang, MD, and Yu-Chen Huang, MD, of Taipei Medical University Hospital, Taiwan, performed a literature search in PubMed, MEDLINE, and EmBase databases from inception through October 31, 2016. They searched the terms “Demodex” and “Demodex Mites” combined with “Rosacea.” All studies included in their review and meta-analysis were human clinical trials published in English.
http://medestheticsmag.com/new-evidence-demodex-mite-infestations-rosacea
Thursday, August 17, 2017 - 14:10
Aesthetic laser and light system manufacturer Sciton is celebrating is celebrating its 20-year anniversary this year with a limited-time website and a two-day User Summit scheduled for November 11-12, 2017. The new Sciton website offers a brief history of the company’s product development, physician testimonials, and profiles of long-term employees.
http://medestheticsmag.com/sciton-celebrates-20-year-anniversary

Advertisement - Box 3

Advertisement - Box 4

Thursday, August 10, 2017 - 11:49
Larry Brilliant, MD, MPH, will deliver the opening keynote address at the 2017 Annual Meeting of the American Society for Dermatologic Surgery (ASDS) on October 5 in Chicago.
http://medestheticsmag.com/larry-brilliant-md-open-2017-asds-meeting
Thursday, August 10, 2017 - 11:49
Larry Brilliant, MD, MPH, will deliver the opening keynote address at the 2017 Annual Meeting of the American Society for Dermatologic Surgery (ASDS) on October 5 in Chicago.
http://medestheticsmag.com/larry-brilliant-md-open-2017-asds-meeting
Thursday, August 10, 2017 - 11:00
Bonti, a clinical-stage biotechnology company, has announced topline results of the first clinical study of its lead product candidate, EB-001, in glabellar lines. EB-001 is a novel serotype E botulinum neurotoxin with a unique efficacy profile, characterized by fast onset of action (about 24 hours) and short duration of effect (about 4 weeks).
http://medestheticsmag.com/bonti-releases-phase-2a-clinical-study-data-its-botulinum-toxin-product

Pages

Advertisement - Box 5

Advertisement - Box 6